5% stakes
Tang Capital Management
Institution
- 5% stake reports
- 42
- 5% stake stocks
- 26
- Latest report
- 26/08/21
5% stake reports
| Stock | ||
|---|---|---|
| Nano Dimension NNDM08/21 | 9.1%19,232,538 sh | +1.2pp |
| Nano Dimension NNDM07/27 | 7.9%16,715,812 sh | +1.1pp |
| Fulcrum Therapeutics FULC07/15 | 10.4%6,913,329 sh | +2.2pp |
| Nano Dimension NNDM06/30 | 6.8%14,292,813 sh | First report |
| Boundless Bio BOLD06/29 | 11.3%2,533,845 sh | First report |
| Fulcrum Therapeutics FULC06/10 | 8.2%5,451,800 sh | First report |
| Aurinia Pharmaceuticals AUPH06/04 | 10%13,044,106 sh | +0.8pp |
| Crescent Biopharma CBIO05/15 | 4.21%1,160,000 sh | −0.8pp |
| PureTech Health PTCHF04/29 | 5.19%12,635,782 sh | First report |
| Aurinia Pharmaceuticals AUPH03/25 | 9.2%12,229,500 sh | +0.0pp |
| Aurinia Pharmaceuticals AUPH03/03 | 9.2%12,229,500 sh | +1.9pp |
| Adicet Bio ACET02/17 | 0.1%6,158 sh | −9.8pp |
| Nkarta NKTX02/17 | 2.1%1,480,823 sh | −7.8pp |
| Spyre Therapeutics SYRE02/17 | 2.4%1,892,200 sh | −2.9pp |
| Precision Biosciences DTIL02/17 | 0%0 sh | −6.4pp |
| Cybin HELP02/17 | 0%0 sh | −9.1pp |
| Keros Therapeutics KROS02/17 | 0%0 sh | −7.9pp |
| Evolus EOLS02/17 | 1.92%1,245,692 sh | −6.0pp |
| CytomX Therapeutics CTMX02/17 | 0%0 sh | −7.0pp |
| Tarsus Pharmaceuticals TARS02/17 | 2.8%1,188,624 sh | −3.1pp |
